Its expression is regulated by key metabolic hormones, such as insulin, glucagon, and pro-inflammatory cytokines, and elevated circulating levels are frequently observed in individuals with obesity, type 2 diabetes, and other metabolic disorders, potentially reflecting a compensatory response aimed at mitigating an energy imbalance and insulin resistance [13]. The gene discussed is INS; the disease is Other metabolic disease.